The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia

Medical Care

Volumn 46, Issue 7, 2008, Pages 686-691

  Owen, Richard R ^a,b,e   Hudson, Teresa ^a,b   Thrush, Carol ^c   Thapa, Purushottam ^b,d   Armitage, Tracey ^a   Landes, Reid D ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Division of Behavioral Health Services   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Antipsychotic agents; Guideline implementation; Medication management; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MONOTHERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; STRATEGIC PLANNING; TREATMENT RESPONSE; ADOLESCENT; AGED; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGY; HEALTH CARE QUALITY; MIDDLE AGED; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; SCHIZOPHRENIA; UNITED STATES;

EID: 49249091770     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181653d43     Document Type: Article

References (40)

1. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 1997;154(suppl 4):1-63.
2. Lehman AF, Steinwachs DM. Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24:1-10.
3. Mental Health Strategic Health Care Group, The Psychosis Working Group, Office of Performance and Quality. Veterans Health Administration clinical guideline for management of persons with psychoses. Washington, DC: Department of Veterans Affairs; 1997.
4. Rosenheck RA, Desai R, Steinwachs D, et al. Benchmarking treatment of schizophrenia: a comparison of service delivery by the national government and by state and local providers. J Nerv Ment Dis. 2000; 188:209-216.
5. Owen RR, Feng W, Thrush CR, et al. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv. 2001;52:1523-1525.
6. Walkup JT, McAlpine DD, Olfson M, et al. Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry. 2000;61:344-348.
7. Leslie DL, Rosenheck RA. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors. Med Care. 2001;39:923-933.
8. Young AS, Sullivan G, Burnam MA, et al. Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry. 1998;55:611-617.
9. Valenstein MD, Copeland L, Owen R, et al. Delays in adopting evidence-based dosages of conventional antipsychotics. Psychiatr Serv. 2001;52:1242-1244.
10. Chen RS, Nadkarni PM, Levin FL, et al. Using a computer database to monitor compliance with pharmacotherapeutic guidelines for schizophrenia. Psychiatr Serv. 2000;51:791-794.
11. Hudson TJ, Owen RR, Thrush CR, et al. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J Clin Psychiatry. 2008;69:74-80.
12. Green LW, Kreuter MW, Deeds SG, et al. Health education planning model (PRECEDE). In Green LW, et al, eds. Health Education Planning: A Diagnostic Approach. Palo Alto, CA: Mayfield Publishing Co; 1979:2-17.
13. Sawin CT, Walder DJ, Bross DS, et al. Diabetes process and outcome measures in the Department of Veterans Affairs. Diabetes Care. 2004; 27:B90-B94.
14. Owen RR, Cannon D, Thrush CR. Mental Health QUERI Initiative: expert ratings of criteria to assess performance for major depressive disorder and schizophrenia. Am J Med Qual. 2003;18:15-20.
15. Hudson TJ, Owen RR, Thrush CR, et al. A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry. 2004;65:211-216.
16. Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. JConsult Clin Psychol. 1985;53:666-671.
17. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol. 1982;50:950-971.
18. Sackett DL, Gibson ES, Taylor DW, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205-1207.
19. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
20. Barnes TR. A rating scale for drug-induced Akathisia. Br JPsychiatry. 1989;154:672-676.
21. Cuffel BJ, Fischer EP, Owen RR Jr, et al. An instrument for measurement of outcomes of care for schizophrenia: issues in development and implementation. Eval Health Prof. 1997;20:96-108.
22. Fischer EP, Cuffel BJ, Owen RR, et al. Schizophrenia Outcomes Module User's Manual. Little Rock, AR: University of Arkansas for Medical Sciences; 1996.
23. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484.
24. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.
25. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Expressed emotion, affective style, lithium compliance, and relapse in recent onset mania. Psychopharmacol Bull. 1986;22:628-632.
26. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry. 1988;45:225-231.
27. Ware JE Jr, Snow KK, Kosinski M, et al. SF-36 health survey manual and interpretation guide. Boston, MA: Health Institute, New England Medical Center; 1993.
28. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Schizophrenia. Washington, DC: American Psychiatric Association; 2004.
29. Geddes J, Freemantle N, Harrison P, et al. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321:1371-1376.
30. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsy- chotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
31. Marder SR, Essock SE, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334-1349.
32. Kashner TM, Carmody TJ, Suppes T, et al. Catching up on health outcomes: the Texas Medication Algorithm Project. Health Serv Res. 2003;38:311-331.
33. Treatment of schizophrenia: the expert consensus panel for schizophrenia. J Clin Psychiatry. 1996;57(Suppl 12B):3-58.
34. Miller AL, Crismon ML, Rush AJ, et al. The Texas Medication Algorithm Project: clinical results for schizophrenia. Schizophr Bull. 2004; 30:627-647.
35. Owen RR, Thrush CR, Hudson TJ, et al. Using an explicit guideline- based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia. Int JQual Health Care. 2002;14:199-206.
36. West JC, Wilk JE, Olfson M, et al. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv. 2005;56:283-291.
37. Owen RR, Thrush CR, Kirchner JE, et al. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int Qual Health Care. 2000;12:475-482.
38. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophr Bull. 1998;24:11-20.
39. Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harvard Rev Psychiatr. 2002;10:138 -153.
40. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001; 39(8 Suppl 2):II-2-II-45.